Drug
C16g2 Rinse
C16g2 Rinse: highest development phase Phase 2, developed by Armata Pharmaceuticals. 1 trial record tracked on RxWires.
- Highest phase
- Phase 2
- Developer
- Armata Pharmaceuticals
Trials
| Drug | Phase | Indication |
|---|---|---|
| C16G2 Rinse NCT02044081 | Phase 2 | Dental Caries |
Latest
No recent events.
Follow C16g2 Rinse on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.